2025-2033 年日本给药装置市场报告（按给药途径、应用、最终用户和地区）

2024 年日本给药装置IMARC Group规模达到 127 亿美元。这些设备的市场是由慢性病盛行率上升、药物研究的进步以及新型药物输送技术的不断发展所推动的。

药物输送装置是医疗设备的基本组成部分，旨在透过人体内的不同途径施用药物和治疗剂。它们专门用于确保精确、受控和有针对性的药物输送，以达到最佳治疗效果，同时最大限度地减少副作用。它们涵盖多种形式，包括但不限于注射器、吸入器、贴片和可植入装置。药物输送设备的发展对于满足对有效给药治疗各种疾病和病症的创新解决方案日益增长的需求至关重要。它们还在改变治疗实践方面发挥关键作用，从而为医疗保健解决方案的进步做出了重大贡献。

日本给药装置市场趋势：

日本给药设备市场正在经历一个大幅成长和转型的阶段，在几个关键驱动因素的推动下，并以新兴趋势为标誌。主要驱动因素是日本慢性病盛行率不断上升和人口老化，需要先进的治疗方法和有效的药物传输系统。这些健康状况需要加强医疗关注和创新治疗解决方案，为复杂的药物输送设备在该国的扩散铺平道路。日本对研究和开发的高度重视是另一个重要的催化剂，促进了药物传递技术的创新和进步。强调开发更方便、更有效率、侵入性更小的以患者为中心的设备正在推动市场个人化和客製化的趋势。技术进步导致新型药物输送系统的出现，旨在优化治疗结果并减轻不良反应。此外，支持性的监管环境和对医疗保健的大量投资正在促进新技术的快速采用，并确保这些设备的安全性和有效性。消费者意识和医疗保健素养的提高也促进了对先进药物输送设备的需求不断增长。奈米技术与药物输送的融合代表了一个值得注意的趋势，为创建具有更高精度和控制能力的设备提供了机会。从本质上讲，创新技术、不断增长的医疗保健需求和有利的监管环境的结合正在塑造日本给药设备市场的发展轨迹，凸显出充满创新和机会的光明前景。

日本药物输送设备市场细分：

管理途径见解：

• 可注射
• 专题
• 眼睛
• 其他的

应用见解：

• 癌症
• 心血管
• 糖尿病
• 传染病
• 其他的

最终使用者见解：

• 医院
• 门诊手术中心
• 其他的

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 到目前为止，日本给药设备市场的表现如何，未来几年将如何表现？
• COVID-19 对日本给药设备市场有何影响？
• 日本给药装置市场依给药途径划分是怎样的？
• 日本给药装置市场按应用划分是怎样的？
• 日本给药装置市场以最终用户划分是怎样的？
• 日本给药器材市场价值链的各个阶段是什么？
• 日本给药装置的关键驱动因素和挑战是什么？
• 日本给药装置市场的结构如何？
• 日本给药装置市场的竞争程度如何？

本报告回答的关键问题：

• 到目前为止，日本给药设备市场的表现如何，未来几年将如何表现？
• COVID-19 对日本给药设备市场有何影响？
• 日本给药装置市场依给药途径划分是怎样的？
• 日本给药装置市场按应用划分是怎样的？
• 日本给药装置市场以最终用户划分是怎样的？
• 日本给药器材市场价值链的各个阶段是什么？
• 日本给药装置的关键驱动因素和挑战是什么？
• 日本给药装置市场的结构如何？
• 日本给药装置市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

• 研究目的
• 利害关係人
• 数据来源
  • 主要来源
  • 二手资料
• 市场预测
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章：执行摘要

第 4 章：日本给药装置市场 - 简介

• 概述
• 市场动态
• 产业动态
• 竞争情报

第 5 章：日本给药装置市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第 6 章：日本给药器材市场 - 细分：依给药途径

• 可注射
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 专题
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 眼睛
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 其他的
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第 7 章：日本给药装置市场 - 细分：依应用分类

• 癌症
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 心血管
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 糖尿病
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 传染病
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 其他的
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第 8 章：日本给药装置市场 - 细分：依最终使用者划分

• 医院
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 门诊手术中心
  • 概述
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）
• 其他的
  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第 9 章：日本给药装置市场 - 竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳制胜策略
• 竞争仪表板
• 公司评估象限

第 10 章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 11 章：日本给药装置市场 - 产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 司机
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 12 章：附录

Japan drug delivery devices market size reached USD 12.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025-2033. The market for these devices is driven by the rising prevalence of chronic diseases, advancements in pharmaceutical research, and the continual development of novel drug delivery technologies.

Drug delivery devices constitute a fundamental component of medical equipment designed to administer medications and therapeutic agents across diverse routes in the human body. They are specifically to ensure precise, controlled, and targeted delivery of drugs to achieve optimal therapeutic effect while minimizing side effects. They encompass a variety of forms including, but not limited to, injectors, inhalers, patches, and implantable devices. The evolution of drug delivery devices is crucial in addressing the growing need for innovative solutions to administer medication effectively to treat various diseases and conditions. They also play a pivotal role in transforming therapeutic practices, thereby contributing significantly to the advancement of healthcare solutions.

Japan Drug Delivery Devices Market Trends:

The Japan drug delivery devices market is traversing a phase of substantial growth and transformation, propelled by several pivotal drivers and marked by emerging trends. A primary driver is the escalating prevalence of chronic diseases and aging population in Japan, necessitating advanced therapeutic approaches and effective drug delivery systems. These health conditions demand enhanced medical attention and innovative therapeutic solutions, paving the way for the proliferation of sophisticated drug delivery devices in the country. Japan's strong focus on research and development is another significant catalyst, fostering innovations and advancements in drug delivery technologies. The emphasis on developing patient-centric devices that are more convenient, efficient, and less invasive is driving the trend of personalization and customization in the market. Technological advancements are leading to the emergence of novel drug delivery systems, aiming to optimize therapeutic outcomes and mitigate adverse effects. Moreover, a supportive regulatory environment and substantial investments in healthcare are facilitating the rapid adoption of new technologies and ensuring the safety and efficacy of these devices. The increasing consumer awareness and healthcare literacy are also contributing to the growing demand for advanced drug delivery devices. The convergence of nanotechnology with drug delivery represents a noteworthy trend, offering opportunities for creating devices with enhanced precision and control. In essence, the amalgamation of innovative technologies, burgeoning healthcare needs, and a conducive regulatory landscape is shaping the trajectory of the drug delivery devices market in Japan, highlighting a promising outlook filled with innovations and opportunities.

Japan Drug Delivery Devices Market Segmentation:

Route of Administration Insights:

• Injectable
• Topical
• Ocular
• Others

Application Insights:

• Cancer
• Cardiovascular
• Diabetes
• Infectious diseases
• Others

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan drug delivery devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan drug delivery devices market?
• What is the breakup of the Japan drug delivery devices market on the basis of route of administration?
• What is the breakup of the Japan drug delivery devices market on the basis of application?
• What is the breakup of the Japan drug delivery devices market on the basis of end user?
• What are the various stages in the value chain of the Japan drug delivery devices market?
• What are the key driving factors and challenges in the Japan drug delivery devices?
• What is the structure of the Japan drug delivery devices market and who are the key players?
• What is the degree of competition in the Japan drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Delivery Devices Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Drug Delivery Devices Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Drug Delivery Devices Market - Breakup by Route of Administration

• 6.1 Injectable
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Topical
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Ocular
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Others
  • 6.4.1 Historical and Current Market Trends (2019-2024)
  • 6.4.2 Market Forecast (2025-2033)

7 Japan Drug Delivery Devices Market - Breakup by Application

• 7.1 Cancer
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiovascular
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Infectious Diseases
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Delivery Devices Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Others
  • 8.3.1 Historical and Current Market Trends (2019-2024)
  • 8.3.2 Market Forecast (2025-2033)

9 Japan Drug Delivery Devices Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Drug Delivery Devices Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix